Prevalencia y malignidad asociada de las citologías de categoría Bethesda III de nódulos tiroideos según el grupo «atipia citológica» o «atipia arquitectónica»

Cibas, 2009, The 2017 Bethesda system for reporting thyroid cytopathology, Am J Clin Pathol, 132, 658, 10.1309/AJCPPHLWMI3JV4LA Nishino, 2014, Should the thyroid AUS/FLUS category be further stratified by malignancy risk?, Cancer Cytopathol, 122, 481, 10.1002/cncy.21412 Cibas, 2017, The Bethesda system for reporting thyroid cytopathology, Thyroid, 27, 1341, 10.1089/thy.2017.0500 Heller, 2014, Malignancy rate in thyroid nodules classified as Bethesda category III (AUS/FLUS): Is there a correct answer?, Thyroid, 24, 787, 10.1089/thy.2014.0142 Ho, 2014, Malignancy rate in thyroid nodules classified as Bethesda category III (AUS/FLUS), Thyroid, 24, 832, 10.1089/thy.2013.0317 López, 2015, Riesgo de malignidad de los nódulos tiroideos con atipia de significado incierto, Endocrinol Nutr, 62, 507, 10.1016/j.endonu.2015.06.007 Tamhane, 2016, Thyroid nodule update on diagnosis and management, Clin Diabetes Endocrinol, 2, 17, 10.1186/s40842-016-0035-7 Padmanabhan, 2017, Diagn Cytopathol, 45, 399, 10.1002/dc.23681 Ferris, 2015, American Thyroid Association Surgical Affairs Committe American Thyroid Association statement on surgical application of molecular profiling for thyroid nodules: Current impact on perioperative decision making, Thyroid, 25, 760, 10.1089/thy.2014.0502 Haugen, 2016, 2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer, Thyroid, 26, 1, 10.1089/thy.2015.0020 Na, 2015, Role of core needle biopsy in the management of atypia/follicular lesion of undetermined significance thyroid nodules: Comparison with repeat fine-needle aspiration in subcategory nodules, Eur Thyroid J, 4, 189, 10.1159/000437051 De Koster, 2018, Diagnostic utility of molecular and imaging biomarkers in cytological indeterminate thyroid nodules, Endocr Rev, 39, 154, 10.1210/er.2017-00133 Brito, 2014, The accuracy of thyroid nodule ultrasound to predict thyroid cancer: systematic review and metaanalysis, J Clin Endocrinol Metab, 99, 1253, 10.1210/jc.2013-2928 Remonti, 2015, Thyroid ultrasound features and risk of carcinoma: A systematic review and meta-analysis of observational studies, Thyroid, 25, 538, 10.1089/thy.2014.0353 Renshaw, 2010, Should “atypical follicular cells” in thyroid fine-needle aspirates be subclassified?, Cancer Cytopathol, 118, 186, 10.1002/cncy.20091 Renshaw, 2011, Subclassification of atypical cells of undetermined significance in direct smears of fine-needle aspirations of the thyroid, Cancer Cytopathol, 119, 322, 10.1002/cncy.20154 Shrestha, 2016, Cytologic subclassification of atypia of undetermined significance may predict thyroid nodules more likely to be malignant at surgery, Diag Cytopathol, 44, 492, 10.1002/dc.23472 Chandra, 2017, Malignancy rate in thyroid nodules categorized as atypia of undeterminated significance of follicular lesion of undetermined significance. An institucional experience, J Cytol, 34, 144, 10.4103/JOC.JOC_234_16 Gan, 2017, Thyroid cytology-nuclear versus architectural atypia within the “Atypia of undetermined significance/follicular lesion of undetermined significance”. Bethesda category have significantly different rates of malignancy, Cancer Cytopathol, 125, 245, 10.1002/cncy.21823 Rosario, 2017, Importance of cytological subclassification of thyroid nodules with Bethesda category III cytology (AUS/FLUS) into architectural atypia only and nuclear atypia: A prospective study, Diag Cytopathol, 45, 604, 10.1002/dc.23734 Valderrabano, 2018, Cancer risk associated with nuclear atypia in cytologically indeterminate thyroid nodules: A systematic review and meta-analysis, Thyroid, 28, 210, 10.1089/thy.2017.0419 VanderLaan, 2011, Usefulness of diagnostic qualifiers for thyroid fine-needle aspirations with atypia of undetermined significance, Am J Clin Pathol, 136, 572, 10.1309/AJCPO0BQ2YSKPXXP Tuttle, 2017, Thyroid differentiated and anaplastic carcinoma Lee, 2016, Subcategorization of Bethesda system category III by ultrasonography, Thyroid, 26, 836, 10.1089/thy.2015.0637 Straccia, 2015, Meta-analytic review of the Bethesda system for reporting thyroid cytopathology: Has the rate of malignancy in indeterminate lesions been underestimated?, Cancer Cytopathol, 123, 713, 10.1002/cncy.21605 Horne, 2012, Thyroid follicular lesion of undetermined significance: evaluation of the risk of malignancy using the two-tier sub-classification, Diagnostic Cytopathol, 40, 410, 10.1002/dc.21790 Rosario, 2014, Thyroid nodules with atypia or follicular lesions of undetermined significance (Bethesda Category III): Importance of ultrasonography and cytological subcategory, Thyroid, 24, 1115, 10.1089/thy.2013.0650 Hyeon, 2014, The prediction of malignant risk in the category “atypia of undetermined significance/follicular lesion of undetermined significance” of the Bethesda System for Reporting Thyroid Cytopathology using subcategorization and BRAF mutation results, Cancer Cytopathol, 122, 368, 10.1002/cncy.21396 Kim, 2017, Risk of malignancy according to subclassification of the atypia of undetermined significance or follicular lesion of undetermined significance (AUS/FLUS) category in the Bethesda system for reporting thyroid cytopathology, Cytopathology, 28, 65, 10.1111/cyt.12352 Ahn, 2017, Comparison of risk of malignancy ina subgroup with atypia of undetermined significance/follicular lesion of undetermined significance: A meta-analysis, Head Neck, 39, 1699, 10.1002/hed.24768 Walts, 2014, Follicular lesion of undetermined significance in thyroid FNA revisited, Diagnostic Cytopathol, 42, 18, 10.1002/dc.23019